海外の治験の状況「1」での検索結果
2901件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Phase I Study Evaluating The Safety And Efficacy of a Device for Collection of Electrical Bioimpedance Data
- Pain
- Israel
- 2008-09-03
Recruiting
- A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
- Solid Tumor
- China
- 2013-03-01
Recruiting
- Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations
- NSCLC;Ovarian Cancer;Melanoma;Other Solid Tumors
- Canada, France, Germany, Japan, Korea, Republic of, Netherlands, Spain, Switzerland, United States
- 2015-11-05
Recruiting
- A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies
- Advanced Solid Malignancies;Advanced Solid Malignancies;Advanced Solid Malignancies;Advanced Solid Malignancies
- China
- 2015-10-08
Recruiting
- First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001
- Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer
- China
- 2016-08-16
Recruiting
- A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
- Glioblastoma
- Israel, Italy, Netherlands
- 2016-08-02
Recruiting
- Phase I Study of Ibuprofenamine Hydrochloride Spray Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers
- Osteoarthritis
- China
- 2016-06-03
Recruiting
- A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL
- Relapsed or Refractory Acute Lymphoblastic Leukemia;Relapsed or Refractory Acute Lymphoblastic Leukemia;Relapsed or Refractory Acute Lymphoblastic Leukemia;Relapsed or Refractory Acute Lymphoblastic Leukemia
- China
- 2017-01-10
Recruiting
- A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics
- Advanced Cancer;Advanced Cancer;Advanced Cancer;Advanced Cancer
- China
- 2017-01-10
Recruiting
- Phase I Study to Evaluate the Tolerability, Pharmacokinetics, Immunogenicity, Safety of Dose Escalation and Preliminary Efficacy of GR1401 in Patients with Advanced Solid Tumors
- Colorectal Cancer, Non-small cell lung cancer, Head and Neck Cancer, Esophageal Cancer, etc.
- China
- 2017-12-31